Cytek Biosciences Inc. 06.08.17
More colors, greater flexibility, higher sensitivity, better affordability. Cytek Biosciences Inc. has launched its new Aurora advanced flow cytometry system, which features a unique combination of patent-pending, innovative technologies that take flow cytometry to the next level of performance and flexibility.
Aurora offers capabilities that go beyond flow cytometry systems, making it the embodiment of Cytek's mission to make massively multiparametric flow cytometry accessible to a larger number of researchers.
Cytek provides services and customization to keep cytometry systems tuned and running at high performance levels. The introduction of Aurora combines the company's pool of technical expertise with its market understanding to mark its full circle evolution from a service provider to a solution provider. "Cytek has evolved to address an unmet need," noted Dr. Wenbin Jiang, CEO of Cytek Biosciences. "Years of experience have revealed to us that the cytometry community has lacked a user-friendly and truly affordable hyper-parametric flow cytometer. Our technology allows us to provide an instrument that offers outstanding performance and unparalleled reagent flexibility when it comes to dye selection and multicolor panel design. With Aurora, more labs will have the ability to obtain deeper biological insights from a single sample. This will have a significant impact on research and clinical application fields such as immunology, oncology and systems biology."
Aurora enables a 20-plus color capability, using three excitation lasers and 50 channels. A system design that includes excitation optics and compact semiconductor detector modules with high quantum efficiency allows for the implementation of more detection channels per laser than conventional flow cytometry systems. Depending on the laser excitation wavelength, this permits detection of any fluorescence emission in the 400-900nm range without having to change optical filters. Aurora's optical design and unmixing algorithm combine to enable the use of a wide array of dyes, including those with highly overlapping spectra—a feat not possible using conventional cytometry.
Aurora joins Cytek's existing lineup of flow cytometry solutions.
Cytek is a flow cytometry solution provider, featuring compact instruments with high multiplexing capability and a wide range of services to support researchers and clinicians. Cytek Biosciences is the outcome of a merger between Cytek Development Inc., a pioneer in flow cytometry, and Cytoville Inc., a venture-capital-backed business focusing on advanced bio-medical instrument technology development. The company's headquarters is in Fremont, Calif., with branch offices and distribution channels worldwide.
Aurora offers capabilities that go beyond flow cytometry systems, making it the embodiment of Cytek's mission to make massively multiparametric flow cytometry accessible to a larger number of researchers.
Cytek provides services and customization to keep cytometry systems tuned and running at high performance levels. The introduction of Aurora combines the company's pool of technical expertise with its market understanding to mark its full circle evolution from a service provider to a solution provider. "Cytek has evolved to address an unmet need," noted Dr. Wenbin Jiang, CEO of Cytek Biosciences. "Years of experience have revealed to us that the cytometry community has lacked a user-friendly and truly affordable hyper-parametric flow cytometer. Our technology allows us to provide an instrument that offers outstanding performance and unparalleled reagent flexibility when it comes to dye selection and multicolor panel design. With Aurora, more labs will have the ability to obtain deeper biological insights from a single sample. This will have a significant impact on research and clinical application fields such as immunology, oncology and systems biology."
Aurora enables a 20-plus color capability, using three excitation lasers and 50 channels. A system design that includes excitation optics and compact semiconductor detector modules with high quantum efficiency allows for the implementation of more detection channels per laser than conventional flow cytometry systems. Depending on the laser excitation wavelength, this permits detection of any fluorescence emission in the 400-900nm range without having to change optical filters. Aurora's optical design and unmixing algorithm combine to enable the use of a wide array of dyes, including those with highly overlapping spectra—a feat not possible using conventional cytometry.
Aurora joins Cytek's existing lineup of flow cytometry solutions.
Cytek is a flow cytometry solution provider, featuring compact instruments with high multiplexing capability and a wide range of services to support researchers and clinicians. Cytek Biosciences is the outcome of a merger between Cytek Development Inc., a pioneer in flow cytometry, and Cytoville Inc., a venture-capital-backed business focusing on advanced bio-medical instrument technology development. The company's headquarters is in Fremont, Calif., with branch offices and distribution channels worldwide.